GlassScriptPhysician profile
Jasmine Loretta Johnson
NPI 1730641283
$947.11
in general payments reported to CMS, 2019-2025
15 companies · $444 in 2025
The $444 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $115 · 2024: $263 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $273.07 | 2024-2025 | Myfembree, Gemtesa |
| Glaxosmithkline, LLC. | $125.01 | 2022 | |
| Viiv Healthcare Company | $72.42 | 2025 | |
| Channel Medsystems, INC. | $57.79 | 2024 | |
| Shield Therapeutics INC | $53.38 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $50.37 | 2024-2025 | Zurzuvae |
| Myriad Women'S Health, INC. | $48.20 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $47.61 | 2025 | Acessa Provu System, Aptima |
| Intuitive Surgical, INC. | $44.62 | 2023-2024 | Da Vinci Surgical System |
| Minerva Surgical, INC | $37.85 | 2023-2025 | |
| Ethicon US, LLC | $35.42 | 2023-2025 | Enseal, Harmonic, Vistaseal |
| Organon LLC | $30.23 | 2024 | |
| Teleflex LLC | $26.46 | 2025 | Quikclot |
| Astellas Pharma US INC | $26.23 | 2024 | Veozah |
| Abbvie INC. | $18.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.